Top 10 US Specialty Pharmacies Shaping Access 2026
Three PBM-owned pharmacies control two-thirds of specialty drug dispensing revenue — here’s the full landscape access teams need to navigate.
Read MoreIndustry Intelligence
In-depth market analysis and data-driven reports on the pharmaceutical industry — covering pricing trends, capacity shifts, regulatory impact, and the commercial dynamics across manufacturing, logistics, and access.
Three PBM-owned pharmacies control two-thirds of specialty drug dispensing revenue — here’s the full landscape access teams need to navigate.
Read MoreVizient and Premier alone represent over 60% of US hospital beds — here’s the full GPO landscape shaping formulary and
Read MoreSmall dispensers hit their final DSCSA deadline November 27, 2026 — here are the ten serialization vendors that can get
Read MoreThe pharma 3PL market hits $73 billion in 2026 — here are the ten distribution partners with the warehousing scale
Read MoreThree companies process 80% of all US prescription claims — here’s the full PBM and market access landscape hospital pharmacy
Read MoreThe global pharma cold chain market is racing to $48.76B by 2035 — here are the ten logistics providers that
Read MoreWith 350+ USFDA-registered facilities and 30-40% lower costs, these are the Indian CDMOs capturing China+1 diversification demand in 2026. India
Read MoreWith 74% of Europe’s APIs still sourced from Asia, these are the UK and EU CDMOs positioned to capture reshoring
Read MoreThe US CDMO market is racing past $39 billion as sponsors reshore from China — here’s who actually has the
Read More